Loading company…
Noetik develops AI tools and research platforms for cancer immunotherapy.
Founded in 2022 and based in California, US, Noetik develops AI-based cancer research tools using self-supervised learning and multimodal human data. Its software is designed to help researchers study cancer and oncology treatments. In March 2026, the company raised USD 50 million from GlaxoSmithKline Plc to accelerate AI-driven cancer research.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in